𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New Approaches in the Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells toward Hepatocytes

✍ Scribed by Iman Saramipoor Behbahan; Yuyou Duan; Alexander Lam; Shiva Khoobyari; Xiaocui Ma; Tijess P. Ahuja; Mark A. Zern


Publisher
Humana Press Inc
Year
2011
Tongue
English
Weight
370 KB
Volume
7
Category
Article
ISSN
1550-8943

No coin nor oath required. For personal study only.

✦ Synopsis


Orthotropic liver transplantation is the only established treatment for end-stage liver diseases. Utilization of hepatocyte transplantation and bio-artificial liver devices as alternative therapeutic approaches requires an unlimited source of hepatocytes. Stem cells, especially embryonic stem cells, possessing the ability to produce functional hepatocytes for clinical applications and drug development, may provide the answer to this problem. New discoveries in the mechanisms of liver development and the emergence of induced pluripotent stem cells in 2006 have provided novel insights into hepatocyte differentiation and the use of stem cells for therapeutic applications. This review is aimed towards providing scientists and physicians with the latest advancements in this rapidly progressing field.


πŸ“œ SIMILAR VOLUMES


Chromatin remodeling in Embryonic stem c
✍ Bridget Keenen; Ivana L. de la Serna πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

## Abstract Embryonic stem cells have an unlimited potential for self‐renewal yet are pluripotent, capable of differentiating into three different germ layers and ultimately into multiple cell lineages. Key pluripotency specific factors maintain an undifferentiated ES cell phenotype while lineage s

Derivation of murine induced pluripotent
✍ Feng Li; Sarah Bronson; Christopher Niyibizi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 418 KB πŸ‘ 1 views

## Abstract Induced pluripotent stem cells (iPSCs) have generated hope and excitement because of the potential they possess for generating patient‐specific embryonic‐like stem cells (ESCs). Although many hurdles remain to be solved before the cells can be applied clinically; studies directed toward